Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa).
- Citation:
- J Clin Oncol vol 32 (15_suppl) 506
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2304
- Pharmas:
- Grants:
- Corr. Author:
- Lisa A. Carey
- Authors:
- Lisa A. Carey William Thomas Barry Brandy Pitcher Katherine A. Hoadley Maggie Chon U. Cheang Carey K. Anders N. Lynn Henry Sara M. Tolaney Chau T. Dang Ian E. Krop Lyndsay Harris Donald A. Berry Charles M. Perou Eric P. Winer Clifford A. Hudis
- Networks:
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: